Comparison of volumetric and linear measurements of intestinal inflammation and treatment response in children with newly diagnosed ileal Crohn disease. [PDF]
Eur RadiolDerinkuyu BE +5 more
europepmc +1 more source
Meta‐Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease
Alimentary Pharmacology &Therapeutics, EarlyView.Eating disorders are common among individuals with IBD, with prevalence estimates ranging from 3% to 14% depending on the assessment method. Findings highlight the need for validated screening tools tailored to IBD. ABSTRACT Background and Aims Disentangling whether disordered eating is a cause, consequence or manifestation of inflammatory bowel ...
Quinn Goddard +6 more
wiley +1 more source
Hematopoietic stem cell transplantation therapy for refractory' Crohn disease: A systematic review and meta-analysis. [PDF]
Medicine (Baltimore)Serrano-Fernandez V +7 more
europepmc +1 more source
CASE REPORT OF CROHN DISEASE WITH HYDRONEPHROSIS COMPLICATIONS
, 2004 Yoshiki Ohkita +3 more
openalex +2 more sources
Protein tyrosine phosphatases as emerging targets for cancer immunotherapy
British Journal of Pharmacology, EarlyView.Abstract Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear.
Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang
wiley +1 more source
Fecal calprotectin as an inflammatory biomarker in small bowel Crohn disease. [PDF]
Porto Biomed JSousa MI, Dias E, Andrade P, Macedo G.
europepmc +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World Data. [PDF]
Ther Drug MonitIrie K +6 more
europepmc +1 more source